Compare EBS & XPER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EBS | XPER |
|---|---|---|
| Founded | 1998 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 303.3M | 271.2M |
| IPO Year | 2006 | 2021 |
| Metric | EBS | XPER |
|---|---|---|
| Price | $5.10 | $5.37 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $10.00 | ★ $11.40 |
| AVG Volume (30 Days) | ★ 946.0K | 399.2K |
| Earning Date | 11-02-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 125.83 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $742,900,000.00 | $448,105,000.00 |
| Revenue This Year | N/A | $1.90 |
| Revenue Next Year | $7.03 | $4.49 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.36 | $4.91 |
| 52 Week High | $14.06 | $8.75 |
| Indicator | EBS | XPER |
|---|---|---|
| Relative Strength Index (RSI) | 27.56 | 40.53 |
| Support Level | $4.36 | $4.91 |
| Resistance Level | $7.18 | $5.92 |
| Average True Range (ATR) | 0.42 | 0.27 |
| MACD | -0.10 | -0.04 |
| Stochastic Oscillator | 3.79 | 13.93 |
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
Xperi Inc is a media and entertainment technology company. Its technologies are integrated into consumer devices, connected cars, and a variety of media platforms globally, enabling audiences to connect with entertainment content in a more intelligent, immersive, and personal way. As its audiences engage with content on the platform, the company operates a cross-screen advertising solution that enables brands to reach millions of engaged consumers across rapidly expanding digital entertainment ecosystem. It operates in one reportable business segment and group its revenue into four categories: Pay-TV, Consumer Electronics, Connected Car and Media Platform. Geographically it operates in U.S. and Canada, Asia Pacific, Europe, Middle East and Africa, and Other countries.